Using a recently described method for efficiently deriving homozygous targeted alleles in embryonic stem cells, we produced chimeric mice whose tissues were derived partially from embryonic stem cells bearing homozygous deletion of the mouse immunoglobulin heavy-chain joining (JH) region. Characterization of these chimeric mice indicated that homozygous JH deletion leads to arrest of B-cell development at an early stage, resulting in a total lack of peripheral B cells and serum IgM. These results were confirmed in mice containing the homozygous JH deletion in their germ line. This novel B-cell-deficient mouse strain provides a tool for studying the recombination and expression of exogenous immunoglobulin genes introduced into the mouse germ line.
Generation of mice with specific mutations in the immunoglobulin (Ig) loci, via gene targeting in mouse embryonic stem (ES) cells, can be a powerful approach for elucidating the processes of Ig gene assembly and expression and their role in B-cell development. Such mice could obviate the limitations associated with studies of transformed cell lines (1) or mice carrying Ig transgenes in a background of functional endogenous Ig genes (2) .
One valuable model system would be a mouse in which the process of Ig gene assembly is completely arrested. The failure of SCID (3) and RAG-deficient (4, 5) mice to properly assemble Ig genes and to produce antibodies is due to mutant genes that act in trans to impair rearrangement of the Ig and T-cell receptor genes. Thus, reconstitution of B-cell development with unrearranged Ig transgenes cannot be studied in these mutant hosts.
Our strategy to impair Ig gene assembly was to mutate a crucial cis-acting sequence involved in this process. As joining of the diversity (D) and heavy-chain joining (JH) gene segments is thought to be a prerequisite for heavy-chain variable region (VH)-D rearrangement, light-chain gene rearrangement, and B-cell differentiation (1, 6, 7) , disruption of this event by gene targeting might be sufficient to prevent Ig heavy-chain gene assembly and therefore block B-cell development and antibody production, thus providing a suitable host for introduction of unrearranged Ig transgenes.
To this end we deleted the JH region from one allele by gene targeting in ES cells. Furthermore, from single allele-targeted ES cells, we selected a homozygous mutant ES cell clone which gave rise to chimeric mice with a homozygous mutant B lineage, for evaluating the effect ofthe JH deletion on B-cell development. In addition, chimeric mice were bred to generate mice heterozygous and homozygous in their germ line for the JH deletion (AJH).
MATERIALS AND METHODS
Targeting-Vector Construction. Plasmid pUC18-JH, containing a 6.1-kb EcoRI genomic fragment of the mouse Ig heavy-chain (Igh) locus (8) , was digested with Xho I and Nae I to delete the 2296-bp fragment containing the entire JH region and the DQ52 gene segment, which was replaced by a 1150-bp Xho I-BamHI fragment of pMClNeopolA (9, 10) showed that only the 3467-bp fragment contained neo sequences and demonstrated the absence of additional random integration events. Deletion of the JH region from the targeted allele was confirmed with probe c, which detected only the 4038-bp fragment. These conclusions were confirmed by analysis of Hindlll-digested DNA (data not shown).
The effect of a recessive genetic mutation such as AJH can be evaluated in mice homozygous for the mutation. However, evaluation of the effect of AJH on Ig expression and B-cell development can be accelerated by AJH-homozygous ES cells, which can be used to produce chimeric mice containing a population of ES-derived lymphoid cells homozygous for the mutant allele. We generated AJHhomozygous ES cells by subjecting the AJH-heterozygous ES 110-1 cell line to elevated levels of G418 (1400 ,g/ml), using a previously described approach (12) . Southern blot analysis of seven of the surviving colonies indicated that one, ES DK207, had lost the native heavy-chain allele and acquired a second, AJH-targeted allele, as evidenced by the inability of probes a and c to detect the wild-type 4038-bp fragment (Fig.  2B ). Karyotypic analysis of ES DK207 (14) Fig. 3A a-d , ES-derived B cells (B220+ IgMa+ or B220+ Ly-9.1+) and T cells (Ly-9.1+ Thy-1.2+) were detected in the peripheral blood of chimeric mice generated from the wild-type ES cells, confirming the ability of this cell line to give rise to lymphoid cells in vivo. Analysis of chimeras generated from AJH-heterozygous ES 65-1 (Fig. 3A e-h ) or ES 110-1 (Fig. 4) (Fig. 4) .
In marked contrast to the wild-type and AJH-heterozygous 65-1 or 110-1 chimeras, mice generated from the AJHhomozygous ES DK207 cell line lacked Ly-9.1+ B220+ or IgMa+ B220+ B cells in peripheral blood (Fig. 3Aj and k) , and virtually all B220+ cells expressed the IgMb allotype (Fig. 3A  1) . The lack of ES-derived peripheral B cells was not due to a block in lymphopoiesis, since ES-derived, Ly-9.1+ B220-cells represented 12% of total PBMCs (Fig. 3A j) . Of these, half were Thy-1.2+ T cells (Fig. 3A i) . Thus, the ES DK207 cell line failed to produce IgMa+ peripheral B cells in chimeric mice but gave rise to both Thy-1.2+ T cells and to an uncharacterized population of Thy-1.2-B220-PBMCs (Fig.  3A i and j) . Similar observations were made in ES DK207 chimeric spleens (Fig. 4) . Our data indicate, therefore, that deletion of the JH region from both alleles, but not from one allele, blocks development of mature IgMa-producing B cells.
The lack of ES-derived peripheral B cells in the DK207 chimeras was corroborated by the absence of serum IgMa. By ELISA, the IgMa serum levels were high (detectable at serum dilutions >2 x 104) in chimeras derived from the wild-type or the AJH-heterozygous ES cell lines (Fig. 3B) , although ESderived B cells represented as few as 4% of the peripheral B cells (Fig. 4) . However, IgMa was undetectable even at the highest concentration of DK207 serum tested (1:20 dilution), indicating a reduction in IgMa by at least a factor of 1000 in DK207 chimeras (Fig. 3B) . Similar levels of IgMb were detected in the sera of all chimeras tested (data not shown). This represents additional evidence that homozygous deletion of the JH region completely blocks B-cell maturation and IgM production.
Analysis of Homozygous AJH-Mutant B-Cell Precursors. To elucidate the stage at which the development of ES DK207-derived B cells is blocked, we analyzed cells from the bone marrow, the primary site of B lymphopoiesis in the adult mouse (17) . Like peripheral blood and spleen, the bone marrow of DK207 chimeras lacked ES-derived IgMa+ B cells but did contain B6-derived IgMb+ B cells (data not shown). However, in contrast to peripheral blood and spleen (Fig. 4 A and E), DK207 chimeric bone marrow contained a small number (2.6-2.9%) of Ly-9.1+ B220+ cells (Fig. 4I) pared to the equivalent populations in 110-1 or 65-1 chimeric mice (Fig. 4J) , in DK207 chimeric mice there was a clear deficit in the brightest Ly-9.1+ B220+ cells, which are mostly IgM+ (ref. 7 and data not shown). This suggested that DK207-derived B220+ bone marrow cells mainly consisted of Ly-9.1+ B220+ IgMa-B-cell precursors, whose maturation to IgMa+ B cells was blocked by homozygous deletion of JH.
To identify these Ly-9.1+ B220+ bone marrow cells as B-cell precursors and determine at what stage of development these precursors were arrested, three-color flow cytometry was performed with antibodies to cell surface markers that define early B-cell precursors (17, 18) : CD43 (18) and Thy-1.2 (19) in conjunction with the Ly-9.1 marker. In addition, by excluding from analysis IgMb+ B cells, we analyzed only B6-derived B-cell precursors (Materials and Methods). As previously reported (7, 20) , these precursor cells expressed lower levels of B220 (B220dull) than mature peripheral B cells. Likewise, most Ly-9.1+ B220+ DK207-derived cells were B220dul (Fig. 5) . However, we did observe a small number of Ly-9.1+ B220bnght cells (Fig. 5 ), but these were not studied further.
Consistent with previous reports (18), B220dull IgM-bone marrow in control B6 and 129 mice contained both CD43bight and CD43dUIl cells (data not shown). Both in control mice (B6, 129) and in the B6-derived pool from chimeric bone marrow, 70 + 17% (mean ± SD, n = 7; range, 53-87%) of B220du1l bone marrow cells were CD43dull (Fig. 5) . However, in the two DK207 chimeric mice analyzed, only 7-18% of B220du11 Ly-9.1+ bone marrow cells were CD43dull (Fig. 5B) . The paucity of CD43dull cells in DK207 bone marrow is consistent with an early block in maturation (18) due to deletion of JH from both alleles.
Like CD43, Thy-1.2 is expressed by B220+ early pro-B cells but is lost as these cells mature, so that pre-B cells (cytoplasmic IgM+, surface IgM-) are Thy-1.2- (19) . From the results obtained for CD43 expression we expected that the majority of DK207-derived B-cell precursors would display Thy-1.2 antigen and few cells would be Thy-1.2-.
Indeed, only 8-18% of the Ly-9.1+ B220dull, DK207-derived bone marrow cells were Thy-1.2- (Fig. SD) , consistent with an early block in maturation. We also noted heterogeneous expression of Thy-1.2 by DK207-derived Ly-9.1+ B220du1 cells, with the brightest Thy-1.2+ cells expressing the lowest levels of B220. It remains a possibility that the Thy-1.2bight cells were mature T lymphocytes whereas the Thy-1.2dull population contained the developmentally arrested B-cell precursors. Finally, another indication of the immaturity of ES DK207-derived B220dull B-cell progenitors was their increased average size compared with B6-derived B220duII IgMb-cells (not shown).
In summary, in ES DK207 chimeric mice, it appears that due to homozygous deletion ofJH, development ofthe ES-derived B lineage is arrested at a stage characterized by relatively large cell size and a B220dull IgM-CD43+ Thy-1.2+ cell surface phenotype, similar to that described for mutant mice (3) (4) (5) and for early precursor populations in normal mice (18) .
Analysis of B Cells in Homozygous AJH-Mutant Mice. Chimeric mice produced from AJH-heterozygous mutant ES 65-1 cell line were mated with B6 mice to obtain mice heterozygous in their germ line for AJH, as demonstrated by Southern blot analysis (Fig. 2C) and by flow cytometry using allotype-specific mAb (data not shown). Heterozygotes were Serum Dilution Although in phenotype the AJH mouse resembles other gene-targeted B-cell-deficient mice (4, 5, 7) , the AJH mouse is uniquely suited for reconstitution with unrearranged Igh transgenes. Unlike the uMT mouse (7), Igh is not expressed in AJH mice, and due to the cis nature of AJH, it should be possible to reconstitute the B lineage with unrearranged autologous or heterologous Igh transgenes. Thus it is now possible to produce transgenic mice that, upon immunization, should produce antibody heavy chains from other species in the absence of endogenous mouse heavy chains. Finally, AJH mice represent a useful model for study of specific B-cell deficiency, of the role of antibodies in the immune response, and of T-cell/B-cell interactions.
